指南与共识甲状腺与浅表US

2020 中国甲状腺结节超声恶性危险分层指南:C-TIRADS

2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.
指南 / 共识 · Endocrine · 2020-08-21

甲状腺结节全球常见,超声在危险分层中作用关键。中国此前有多达十种TIRADS版本并用造成混乱,本指南在中华医学会超声医学分会浅表器官与血管超声学组支持下,基于文献复习、专家共识及中国甲状腺与乳腺超声人工智能联盟多中心数据,制定符合中国国情的C-TIRADS。

要点

  • C-TIRADS由中华医学会超声医学分会浅表器官与血管超声学组支持制定。
  • 制定依据为文献复习、专家共识及中国甲状腺与乳腺超声人工智能联盟多中心数据。
  • 此前中国不同医院使用多达十种TIRADS版本,造成较多混乱。

核心结论

  • C-TIRADS是基于文献复习、专家共识和多中心数据制定、符合中国国情与医疗现状的甲状腺结节超声恶性危险分层系统。

研究设计与样本

  • 指南由中华医学会超声医学分会浅表器官与血管超声学组支持制定,方法为文献复习、专家共识及中国甲状腺与乳腺超声人工智能联盟提供的多中心数据,原文未报告证据分级方法。

临床应用与阅片要点

  • 原文指出超声在确定甲状腺结节危险分层中起重要作用,而危险分层对甲状腺结节的临床管理至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Thyroid nodules are very common all over the world, and China is no exception. Ultrasound plays an important role in determining the risk stratification of thyroid nodules, which is critical for clinical management of thyroid nodules. For the past few years, many versions of TIRADS (Thyroid Imaging Reporting and Data System) have been put forward by several institutions with the aim to identify whether nodules require fine-needle biopsy or ultrasound follow-up. However, no version of TIRADS has been widely adopted worldwide till date. In China, as many as ten versions of TIRADS have been used in different hospitals nationwide, causing a lot of confusion. With the support of the Superficial Organ and Vascular Ultrasound Group of the Society of Ultrasound in Medicine of the Chinese Medical Association, the Chinese-TIRADS that is in line with China's national conditions and medical status was established based on literature review, expert consensus, and multicenter data provided by the Chinese Artificial Intelligence Alliance for Thyroid and Breast Ultrasound.

来源:Endocrine,查看原文。版权归原作者所有。

引用

  1. Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020. PMID: 32827126. doi:10.1007/s12020-020-02441-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。